Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acute, attained, attainment, Australia, Batten, bearing, BPCIA, Brazilian, brian, bring, CA, Carlo, Center, ceroid, CMS, Cork, cybersecurity, dispensing, district, duration, enhanced, enterprise, ETASU, forfeiture, Greece, Greek, Hatch, hematologic, hematological, inadequacy, induction, infantile, infrastructure, input, IP, Irish, Italy, lattice, leukemia, lifted, LINCL, Lindaro, lymphocytic, lymphoma, mantle, matter, methodology, misappropriation, Monte, mueller, multiplied, multiplier, Myasthenia, myelodsplastic, myeloid, Network, neuronal, outlicense, Pathology, peer, percentile, Pfizer, Portugal, pose, preset, problem, qualitative, Quantitative, quickest, Rafael, ranking, ratably, Real, relocate, repayment, requalify, resource, RSU, sabotage, safest, score, Shanbally, shareholder, simulation, slightly, software, Southern, sovereign, Spain, SR, standby, stay, sulfatase, theft, training, TSR, uncollectable, upheld, urinary, velocity, Waxman, withheld, withholding
Filing tables
Filing exhibits
- 10-K Annual report
- 3.3 Certificate of Amendment to Amended and Restated Certificate of Incorporation
- 10.25 Asset Purchase Agreement
- 10.34 Lease Agreement - 770 Lindaro Street
- 10.35 Lease Agreement - 790 Lindaro Street
- 21.1 Subsidiaries of Biomarin Pharmaceutical Inc.
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A)/15D-14(A)
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A)/15D-14(A)
- 32.1 Certification of CEO and CFO Pursuant to Section 906
- 99.1 Biomarin/genzyme LLC Consolidated Financial Statements
Related press release
BMRN similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-168552, 333-136963, 333-85368 and 333-84787) of BioMarin Pharmaceutical Inc. of our report dated February 24, 2011 relating to the financial statements of BioMarin/Genzyme LLC, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 22, 2012